T h e PSI' genetic element was first described by Brian Cox more than 30 years ago as a suppressor of all three non-sense mutations in nutritional markers in some strains of Sacchammyces cerevisiue [ 11. Phenotypically, strains harbouring PSI' behave like yeast strains that harbour other omnipotent suppressors (for review see [2]). However, the inheritance of PSI' exhibits several features which set this element apart: (i) mating and cytoduction experiments suggest that PSI' is inherited as a Abbreviation used: GFP, Green Fluorescent Protein. 'To whom correspondence should be addressed. dominant, cytoplasmic factor [3]; (ii) exhaustive efforts to associate PSI' with a cytoplasmic nucleic acid were inconclusive; (iii) the PSI factor is metastable in that interconversion of strains from psi-to PSI' and vice versa occurs at a low spontaneous frequency [4] .
PSI' has a special relationship with the SUP35 gene which encodes a multi-domain protein that is one subunit of the translation termination factor in yeast ( Figure 1 ). Certain mutations in Sup35 confer a phenotype similar to that of PSI' and these map to an essential C-terminal domain of Sup35 which has homology with the eukaryotic release factor eFW3.
Volume 26 [15] . In experiments comparing the survival of wild-type and Hspl04 mutant yeast during exposure to severe stress, Hspl04 enhanced the chances of survival by two to three orders of magnitude [16] . In vivo analysis of the role of Hspl04 indicate that the protein promotes the resolubilization and reactivation of heat-damaged proteins [17] . Thus, the Hsp1001 Clp family of proteins constitute a new class of molecular machines which specialize in the remodelling of protein aggregates or assemblies.
+ -+ -
Because PSI' is influenced strongly by Hspl04, a protein that helps partition proteins between aggregated and soluble fractions, we decided to investigate whether the aggregation state Sup35 could be readily distinguished in strains differing only in their PSI' status. By differential sedimentation of cell-free lysates derived from PSI' or psi-yeast strains, we determined that Sup35 was largely sedimentable only when PSI' was present [18] . Curing of PSI' by either Hspl04 over-expression or deletion resulted in the recovery of Sup35 solubility. We also obtained evidence to suggest that Hspl04 over-expression may have an unrecognized role in the curing PSI' by a variety of stress-evoking treatments. Under non-stress conditions Hspl04 is barely detectable but is apparently required at this low level to maintain PSI'. Both heat-shock-and stress-response elements occur in the upstream region of the HSP104 gene [20] , and these confer induction in response to heat and a variety of other stresses. For example, the low concentration of guanidinium chloride (5 mM) used to routinely convert PSI' cells to psi-is unlikely to destroy the conformational determinant of the PSI' state directly. More likely, it is the specific induction of Hspl04 under these conditions which is responsible for the curing [21] . Curiously, other conditions in which Hspl04 expression is upregulated, such as entry into stationary phase or heat shock, do not efficiently destabilize PSI'.
Presumably in these cases, other co-regulated physiological changes, including the accumulation of osmolytes and the expression of many other heat-shock proteins, stabilize PSI' or attenuate its interaction with Hspl04.
T o follow the aggregation behaviour of the crucial N-terminal domain of Sup35 in living cells, we constructed a fusion between it and the Green Fluorescent Protein (GFP), and expressed the fusion protein from an inducible promoter. In the presence of pre-existing PSI+ elements the fusion protein coalesced immediately upon induction. We interpreted this behaviour as evidence that pre-existing, aggregated Sup35 in PSI' cells indeed served as a seed for the aggregation of newly synthesized protein carrying the prion determinant of Sup35. In psi-cells, the fusion protein was diffusely distributed. After prolonged expression, the GFP fusion protein began to coalesce into intense foci -a change in aggregation behaviour that correlated with the formation of new heritable PSI' elements.
The same GFP fusion protein also aggregated in psi-cells lacking Hspl04 when it was expressed at high levels for a long time. This suggests that the conformational switch from the Volume 26 soluble to aggregated form of Sup35 could proceed in an Hspl04-independent manner even if, without continued over-expression, propagation of these PSI'-like elements was blocked by the Hspl04 mutation. Indeed, even in the absence of Hspl04, recombinant Sup35 purified from E. coli was initially soluble but, after some time, formed extremely long, rigid fibres [22] . The extreme N-terminal domain of Sup35 and a longer segment composed of this and the highly charged middle domain formed similar structures. In addition to the highly uniform, unbranched morphology typical of amyloid fibres formed by other proteins including PrP and AP, Sup35 fibres also bound Congo red and were enriched in P-sheet secondary structure.
Using either Congo red binding, CD or sedimentation analysis (Figure 3 ) to follow fibre assembly in vim we found that spontaneous fibre formation proceeded in undisturbed solutions only after a lengthy lag period. Most significantly, we found that a small amount of fibre Nonetheless, a direct and specific interaction between Sup35 and Hspl04 has been demonstrated in experiments in which the CD spectrum of a mixture of the two proteins is profoundly different from the spectrum predicted by the arithmetic addition of the spectra of the individual components [23] . Similar results are obtained with peptides derived from PrP. Moreover, Hspl04, as well as the bacterial chaperonin GroEL, enhances the in vim conversion of protease-sensitive PrP to a proteaseresistant form in the presence of infectious PrP" [24] . These experiments suggest that Hspl04 or other molecular chaperones play a direct role in modulating the conformational switches which lead to amyloid formation.
Significantly, Sup35 is the first, and as yet, the only amyloidogenic protein whose aggregation state has been linked to the function of a specific chaperone in a biological context. Certainly the good fortune that this interaction occurs in a model organism that generously accommodates the use of powerful molecular genetic tools is an important factor in the rapid progress in PSI biology in recent years. Just as our research has disclosed the fundamental parity between the molecular mechanism of amyloid formation in mammals and yeast, we expect that the biological and genetic issues that can be addressed in yeast are likely to find parallels in other systems. The extent to which the capacity of molecular chaperones to influence protein conformation may be used in preventing or curing various forms of amyloidosis in humans remains compelling subject matter for future work.
